Evaluation of inert gas rebreathing for determination of cardiac output: influence of age, gender and body size.


Journal

Hypertension research : official journal of the Japanese Society of Hypertension
ISSN: 1348-4214
Titre abrégé: Hypertens Res
Pays: England
ID NLM: 9307690

Informations de publication

Date de publication:
06 2019
Historique:
received: 01 08 2018
accepted: 04 11 2018
revised: 28 10 2018
pubmed: 19 12 2018
medline: 8 9 2020
entrez: 19 12 2018
Statut: ppublish

Résumé

The aim of this study was to evaluate an inert gas rebreathing method (Innocor) for measurement of cardiac output and related haemodynamic variables and to provide robust normative data describing the influence of age, gender and body size on these variables. Four separate studies were conducted: measurement repeatability (study 1, n = 45); postural change (study 2, n = 40); response to submaximal cycling exercise (study 3, n = 20); and the influence of age, gender and body size (study 4, n = 1400). Repeated measurements of cardiac output, stroke volume and heart rate were similar, with low mean (±SD) differences (0.26 ± 0.53 L/min, 0 ± 11 mL and 2 ± 6beats/min, respectively). In addition, cardiac output and stroke volume both declined progressively from supine to seated and standing positions (P < 0.001 for both) and there was a stepwise increase in both parameters moving from rest to submaximal exercise (P < 0.001 for both). In study 4, there was a significant age-related decline in cardiac output and stroke volume in males and females, which remained significant after adjusting for body surface area (BSA, P < 0.001 for all comparisons). Both parameters were also significantly higher in those with high body mass index (BMI; P < 0.01 versus those with normal BMI for all comparisons), although indexing cardiac output and stroke volume to BSA reversed these trends. Inert gas rebreathing using the Innocor device provides repeatable measurements of cardiac output and related indices, which are sensitive to the effects of acute physiological manoeuvres. Moreover, inert gas rebreathing is a suitable technique for examining chronic influences such as age, gender and body size on key haemodynamic components of the arterial blood pressure.

Identifiants

pubmed: 30560890
doi: 10.1038/s41440-018-0179-1
pii: 10.1038/s41440-018-0179-1
pmc: PMC8076049
doi:

Substances chimiques

Noble Gases 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

834-844

Subventions

Organisme : British Heart Foundation
ID : FS/07/001/21990
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/12/33/29561
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/12/8/29377
Pays : United Kingdom

Références

Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
Eur J Clin Nutr. 2000 Jun;54 Suppl 3:S92-103
pubmed: 11041080
J Clin Invest. 1945 Jan;24(1):106-16
pubmed: 16695180
Int J Obes. 1983;7(2):99-107
pubmed: 6862762
AJR Am J Roentgenol. 2006 Jun;186(6 Suppl 2):S357-65
pubmed: 16714609
J Clin Monit Comput. 2008 Dec;22(6):401-8
pubmed: 19005768
J Appl Physiol. 1970 Jun;28(6):863-6
pubmed: 4911617
Exp Gerontol. 1986;21(4-5):367-78
pubmed: 3817043
Cardiology. 2009;114(4):247-54
pubmed: 19672063
Echocardiography. 2007 Sep;24(8):860-6
pubmed: 17767537
Scand J Med Sci Sports. 2015 Feb;25(1):e20-7
pubmed: 24646113
Lung. 2010 Oct;188(5):433-40
pubmed: 20676666
Am J Cardiol. 2007 Feb 1;99(3):404-5
pubmed: 17261407
Int J Sports Med. 2009 Oct;30(10):747-53
pubmed: 19642059
Hypertension. 2004 Jun;43(6):1239-45
pubmed: 15123572
Am J Cardiol. 1998 Sep 1;82(5):621-6
pubmed: 9732891
Circulation. 1970 Dec;42(6):1057-64
pubmed: 4395357
Cardiol Res Pract. 2012;2012:894308
pubmed: 22454777
JAMA. 1978 Oct 6;240(15):1607-10
pubmed: 691146
Int J Cardiovasc Imaging. 2012 Dec;28 Suppl 2:141-7
pubmed: 23139150
Eur J Appl Physiol. 2008 Mar;102(5):593-9
pubmed: 18074146
Thorax. 2010 Apr;65(4):341-5
pubmed: 20388760
Circ Heart Fail. 2017 Mar;10(3):
pubmed: 28283502
Nutrition. 1989 Sep-Oct;5(5):303-11; discussion 312-3
pubmed: 2520314
J Zhejiang Univ Sci B. 2005 Dec;6(12):1157-62
pubmed: 16358372
J Am Coll Cardiol. 2005 Nov 1;46(9):1779-81
pubmed: 16256885
Tohoku J Exp Med. 1979 Aug;128(4):377-87
pubmed: 483306
Acta Physiol Scand. 1982 Mar;114(3):339-43
pubmed: 7136764
Circulation. 1955 Oct;12(4):557-66
pubmed: 13261308
Circulation. 1997 Jul 1;96(1):308-15
pubmed: 9236450
Am J Physiol. 1999 Nov;277(5):H1863-71
pubmed: 10564141
Hypertension. 2005 Jul;46(1):221-6
pubmed: 15867140
J Am Coll Cardiol. 2005 Nov 1;46(9):1753-60
pubmed: 16256881
J Hypertens. 2016 Feb;34(2):290-7
pubmed: 26682781
JACC Cardiovasc Imaging. 2012 Dec;5(12):1191-7
pubmed: 23236967
Clin Sci (Lond). 1980 Dec;59 Suppl 6:343s-354s
pubmed: 6108816
J Appl Physiol (1985). 2004 Feb;96(2):428-37
pubmed: 14715674
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):752-9
pubmed: 17634323
Cardiovasc Res. 1971 Oct;5(4):577-81
pubmed: 5160462
Circulation. 1997 Apr 1;95(7):1837-43
pubmed: 9107171
J Gerontol A Biol Sci Med Sci. 2013 May;68(5):608-16
pubmed: 23160363
Clin Sci (Lond). 2002 Feb;102(2):247-52
pubmed: 11834145
Int J Cardiol. 2009 Aug 14;136(2):248-50
pubmed: 18657870
Circulation. 1968 Aug;38(2):282-8
pubmed: 5666844
Obes Res. 2000 Dec;8(9):605-19
pubmed: 11225709
J Clin Monit Comput. 2004 Dec;18(5-6):373-8
pubmed: 15957629
Cardiol J. 2008;15(1):63-70
pubmed: 18651387
J Clin Monit Comput. 2009 Aug;23(4):233-6
pubmed: 19543798
Eur J Appl Physiol. 2010 Feb;108(3):573-80
pubmed: 19865827
Acta Med Scand. 1964 Oct;176:425-46
pubmed: 14221654
Am Rev Respir Dis. 1975 Feb;111(2):157-65
pubmed: 1111403
Circulation. 1982 Jul;66(1):55-60
pubmed: 7083520
Am J Cardiol. 1985 Apr 15;55(9):1179-84
pubmed: 3984897
Crit Care Med. 2000 Jan;28(1):51-6
pubmed: 10667498
Hypertension. 2016 Aug;68(2):269-75
pubmed: 27324230
Circulation. 2001 Feb 13;103(6):820-5
pubmed: 11171789
BMC Med Imaging. 2009 Jan 21;9:2
pubmed: 19159437

Auteurs

Jessica E Middlemiss (JE)

Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK.

Alex Cocks (A)

Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK.

Kaido Paapstel (K)

Department of Biochemistry, Centre of Excellence for Translational Medicine, University of Tartu, Tartu, Estonia.

Kaisa M Maki-Petaja (KM)

Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK.
Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK.

Ian B Wilkinson (IB)

Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK.

Carmel M McEniery (CM)

Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK. cmm41@cam.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH